Generics
ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets
19 March 2025 - Biopharmaceutical company ANI Pharmaceuticals Inc (Nasdaq:ANIP) announced on Wednesday the launch of its Nitazoxanide Tablets, 500 mg, the generic version of the reference listed drug ...
Newbury Pharmaceuticals secures approval for Macitentan in Denmark
14 March 2025 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has received marketing authorisation for Macitentan Newbury in Denmark.This is the fi...
Mallinckrodt and Endo to merge in USD6.7bn deal to create pharmaceutical leader
13 March 2025 - Pharmaceutical companies Mallinckrodt plc and Endo Inc (OTCQX:NDOI) announced on Thursday that they have entered into a definitive agreement to merge in a stock and cash transaction, f...
Genomma Lab Internacional announces quarterly dividend
7 March 2025 - Genomma Lab Internacional, SAB de CV (BMV: LABB), a Mexico-based over-the-counter pharmaceutical, generic drugs and personal care products company, announced on Thursday a cash dividend...
Veloxis Pharmaceuticals announces US approval of 'pegrizeprument' as non-proprietary name for VEL-101
26 February 2025 - Specialty pharmaceutical company Veloxis Pharmaceuticals Inc, an Asahi Kasei company, announced on Tuesday that it has received approval from the United States Adopted Name (USAN) C...
Aveva Drug Delivery systems introduces generic Fentanyl Transdermal Patch in US
18 February 2025 - Transdermal drug delivery systems specialist Aveva Drug Delivery Systems, a DifGen company, announced on Monday the launch of all strengths of its generic Fentanyl Transdermal Patch...